Sandrine Bernhard

962 total citations
4 papers, 25 citations indexed

About

Sandrine Bernhard is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Sandrine Bernhard has authored 4 papers receiving a total of 25 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Oncology and 1 paper in Epidemiology. Recurrent topics in Sandrine Bernhard's work include Cancer Immunotherapy and Biomarkers (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Urinary and Genital Oncology Studies (2 papers). Sandrine Bernhard is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Urinary and Genital Oncology Studies (2 papers). Sandrine Bernhard collaborates with scholars based in Japan, Spain and Russia. Sandrine Bernhard's co-authors include Sanjeev Mariathasan, Javier Puente, Matt D. Galsky, Ian D. Davis, Jóse Ángel Arranz Arija, Aristotelis Bamias, Jian‐Ri Li, Maria De Santis, Marina Mencinger and Eiji Kikuchi and has published in prestigious journals such as Journal of Clinical Oncology and International Journal of Gynecological Cancer.

In The Last Decade

Sandrine Bernhard

4 papers receiving 25 citations

Peers

Sandrine Bernhard
Fennie Wit Netherlands
Nicolas Flamey United Kingdom
Zakhi Zafrani United Kingdom
Samuel Lawday United Kingdom
Daniel Tadross United Kingdom
Fennie Wit Netherlands
Sandrine Bernhard
Citations per year, relative to Sandrine Bernhard Sandrine Bernhard (= 1×) peers Fennie Wit

Countries citing papers authored by Sandrine Bernhard

Since Specialization
Citations

This map shows the geographic impact of Sandrine Bernhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandrine Bernhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandrine Bernhard more than expected).

Fields of papers citing papers by Sandrine Bernhard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandrine Bernhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandrine Bernhard. The network helps show where Sandrine Bernhard may publish in the future.

Co-authorship network of co-authors of Sandrine Bernhard

This figure shows the co-authorship network connecting the top 25 collaborators of Sandrine Bernhard. A scholar is included among the top collaborators of Sandrine Bernhard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandrine Bernhard. Sandrine Bernhard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
2.
Galsky, Matt D., Jóse Ángel Arranz Arija, Maria De Santis, et al.. (2023). Atezolizumab (atezo) + platinum/gemcitabine (plt/gem) vs placebo + plt/gem for first-line (1L) treatment (tx) of locally advanced or metastatic urothelial carcinoma (mUC): Final OS from the randomized Phase 3 IMvigor130 study.. Journal of Clinical Oncology. 41(6_suppl). LBA440–LBA440. 8 indexed citations
3.
Bamias, Aristotelis, Ian D. Davis, Matt D. Galsky, et al.. (2023). Final overall survival (OS) analysis of atezolizumab (atezo) monotherapy vs chemotherapy (chemo) in untreated locally advanced or metastatic urothelial carcinoma (mUC) from the Phase 3 IMvigor130 study.. Journal of Clinical Oncology. 41(6_suppl). LBA441–LBA441. 10 indexed citations
4.
Mansi, Laura, Martin Demarchi, Fernando Bazán, et al.. (2016). Impact of Chemotherapy Beyond the Third Line in Patients With Recurrent Epithelial Ovarian Cancer. International Journal of Gynecological Cancer. 26(2). 261–267. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026